25 Years of Fearless Science: Leading in immunogenicity risk assessment, immune modulation, and rapid vaccine design.

“We are very pleased with the detail-oriented scientific reports, timeliness, transparency, and accommodating nature of the EpiVax team. We can always count on the EpiVax team when we need them.”


-President, AmbioPharm, Inc.

“I am very fond of EpiVax’s culture. In agreement with its mission statement, the concrete actions the company has undertaken to ameliorate the conditions of the local community and to improve people’s health around the world are exemplary for whoever is in this business.”


Maria Grazia, Adviser, Lab-on-a-chip; University of Rhode Island

“EpiVax reports are very good and beneficial for our work. We have found the science to be highly sophisticated and we’ve learned a great deal from our discussions with the EpiVax team.” 


-Assistant General Manager, Vaccine & Biomedical Research

“I couldn’t be more pleased with the results and the quality of EpiVax reporting. I look forward to continuing to work together.”


– Product Development Manager, U.S. Pharmaceutical Company

“I value our collaborations over the last year and look forward to continuing and looking for additional opportunities in the future.”


-Senior Director, Animal Health Company

“EpiVax scientists were very responsive to our needs. They provided important insight into the project and delivered a comprehensive and articulate report.”


-President & CEO, Palatin Technologies

We are dedicated to applying our tools (in-silico, in-vitro and in-vivo) to re-engineering therapeutic proteins and to designing new vaccines.


We take pride in our ability to put our combined intelligence, experience, and creativity to work to improve human health. Open minds, creative thought and natural curiosity lead to paradigm shifts. Contact us today to learn more.

Corporate Office/Laboratory:
EpiVax, Inc.

188 Valley Street, Suite 424, Providence, RI 02909 USA
ph: 401.272.2123 fax: 401.272.7562

Join our newsletter

We strive to provide our clients, collaborators and everyday immunology enthusiasts with valuable content.  Written by our CSO Dr. Anne De Groot, you can expect up to date vaccine development efforts, upcoming events and so much more from our offices here in Providence, RI.

Click Here